 PHILADELPHIA, Sept. 07, 2021 GLOBE NEWSWIRE -- Passage Bio, Inc. Nasdaq: PASG, a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system CNS disorders, today reported that Maxine Gowen, Ph.D., has been appointed chairwoman of the board of directors for the company, effective August 31. 